Skip to content
type1.science

Kaleido patch pump

ViCentra

A colorful, semi-patch insulin pump used in Europe, notably as a pump partner for Diabeloop DBLG1/DBLG2 automated insulin delivery. The 2026 DBLG2/Dexcom G7 CE launch keeps it relevant in the interoperable AID ecosystem.

Available nowRegulator-approvedpumppatchdiabeloopinteroperableeuropeOfficial site ↗

The scorecard

Interoperability72

Kaleido is a named pump partner for Diabeloop DBLG1 and the new DBLG2/Dexcom G7 European launch.[2]

Reliability58

Commercial device with Diabeloop ecosystem use, but independent large reliability datasets are limited.[3]

Form factor74

Small on-body semi-patch design reduces tubing burden compared with conventional tubed pumps, though it is not a fully disposable pod.[1]

Phone control60

DBLG2 moves control toward a smartphone application in Europe; standalone Kaleido experience still depends on the paired ecosystem.[2]

Capacity45

Compact size limits reservoir advantage versus 300-unit patch pumps.[1]

Access & cost45

Available in selected European markets through Kaleido/Diabeloop channels; not a US-cleared mainstream pump.[2]

The full picture

Kaleido is best understood as a pump-platform option inside Europe’s modular AID ecosystem. It does not dominate attention the way Omnipod does, but Diabeloop’s DBLG2 rollout with Dexcom G7 and Kaleido makes it a live component of the next commercial AID wave.

Sources

  1. [1]Kaleido insulin pump official site · manufacturer
  2. [2]Diabeloop announces CE marking and launch of DBLG2 with Dexcom G7 and Kaleido · manufacturer · 2026-05-11
  3. [3]Diabeloop DBLG1 pump partners include Kaleido · manufacturer · 2026-03-03